Nicholas Investment Partners, LP
Position in AXSM — Axsome Therapeutics, Inc.
CIK 1389574
RANCHO SANTA FE, CA
Position in AXSM
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$24,225,865
+$10,454,454 QoQ
Shares Held
98,974
+21.5% QoQ
Ownership
0.189%
of shares outstanding
% of Portfolio
1.56%
of 13F equity value
Holder Rank
#72
of 503 holders
Holding Since
Mar 2020
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AXSM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Nicholas Investment Partners, LP holds $271,971,066 across 20 Biotechnology names. AXSM ranks #2 (8.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
244,594 | $45,807,564 | |
| 2 | AXSM |
Axsome Therapeutics, Inc.
This page
|
98,974 | $24,225,865 | |
| 3 | XENE |
Xenon Pharmaceuticals Inc.
|
395,844 | $23,893,143 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
311,494 | $23,200,073 | |
| 5 | MIRM |
Mirum Pharmaceuticals, Inc.
|
172,695 | $20,217,403 | |
| 6 | ELVN |
Enliven Therapeutics, Inc.
|
391,529 | $19,870,096 | |
| 7 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
186,769 | $18,206,242 | |
| 8 | CYTK |
Cytokinetics Inc
|
209,071 | $17,810,758 |
All Filings in AXSM
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $24,225,865 | 98,974 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $13,771,411 | 81,478 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $16,723,248 | 91,564 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $5,909,392 | 48,657 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $4,400,456 | 42,154 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $5,081,802 | 43,572 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $857,522 | 10,135 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $910,832 | 10,135 | Shares | Sole | 2024-11-12 | |
| 2024-03-31 | $2,937,916 | 36,816 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $6,577,715 | 82,645 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $27,605,152 | 394,980 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $28,376,364 | 394,884 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $20,997,722 | 340,430 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $15,445,591 | 200,254 | Shares | Sole | 2023-02-10 | |
| 2021-03-31 | $7,845,890 | 138,571 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $16,901,114 | 207,452 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $13,377,615 | 187,756 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,843,154 | 22,401 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $3,341,602 | 56,801 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||